

Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene.
FEBS Lett.
2010;584;5
Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP).
J. Cell. Physiol.
2010;223;3

Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease.
J Immunotoxicol
2009;6;4

Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258.
Lab. Invest.
2009;89;10

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
J. Hepatol.
2009;51;4
Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.
J. Hepatol.
2009;51;4
Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease.
J Immunotoxicol
2009

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Cancer Res.
2009;69;18

Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Gastroenterology
2009;137;1
Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells.
Hepatol. Res.
2009;39;6

Hepatic fibrosis.
Curr. Opin. Gastroenterol.
2009;25;3

Detection of novel biomarkers of liver cirrhosis by proteomic analysis.
Hepatology
2009;49;4

Functional role of the KLF6 tumour suppressor gene in gastric cancer.
Eur. J. Cancer
2009;45;4

Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.
Hepatology
2009;49;3

PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.
Lab. Invest.
2009;89;2
Commentary: Gastroenterology and hepatology: an evolving marriage, not an imminent divorce.
Am. J. Gastroenterol.
2009;104;1

p38-MAPK- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by retinoic acid.
J. Cell. Physiol.
2009;218;1


Hepatic fibrosis -- overview.
Toxicology
2008;254;3

Advances in antifibrotic therapy.
Expert review of gastroenterology & hepatology
2008;2;6



Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology
2008;135;6

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
N. Engl. J. Med.
2008;359;19
Preface. Hepatic fibrosis: pathogenesis, diagnosis, and emerging therapies.
Clin Liver Dis
2008;12;4

Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.
Hepatology
2008;48;3

Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
Eur. J. Cancer
2008;44;13

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer Res.
2008;68;16
Future trends in hepatology: challenges and opportunities.
Hepatology
2008;48;2

KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
J. Clin. Invest.
2008;118;8

The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.
Gastroenterology
2008;135;1


Mechanisms of hepatic fibrogenesis.
Gastroenterology
2008;134;6


Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Gastroenterology
2008;134;5


Experimental models of hepatocellular carcinoma.
J. Hepatol.
2008;48;5
The movement of aquatic mercury through terrestrial food webs.
Science
2008;320;5874

Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis.
Clin. Exp. Immunol.
2008;152;1
Insulin-like growth factor-i regulates Kruppel-like factor-6 gene expression in a p53-dependent manner.
Endocrinology
2008;149;4

Cannabinoids provoke alcoholic steatosis through a conspiracy of neighbors.
Cell Metab.
2008;7;3


Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.
Physiol. Rev.
2008;88;1

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
Hepatology
2007;46;6

A deer in the headlights: BAMBI meets liver fibrosis.
Nat. Med.
2007;13;11


Hepatic fibrogenesis.
Semin. Liver Dis.
2007;27;4
KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
Int. J. Cancer
2007;121;9
Liver fibrosis: from mechanisms to treatment.
Gastroenterol. Clin. Biol.
2007;31;10
Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Int. J. Cancer
2007;121;6


The ecology of childhood overweight: a 12-year longitudinal analysis.
Int J Obes (Lond)
2007;31;9
Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C.
Hepatol. Res.
2007;37;8

In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Oncogene
2007;26;30
Reversibility of hepatic fibrosis and cirrhosis--is it all hype?
Nature clinical practice. Gastroenterology & hepatology
2007;4;5

Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.
Gut
2007;56;5

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
J. Hepatol.
2007;46;4

Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis.
Gut
2007;56;3


Genomics and signaling pathways in hepatocellular carcinoma.
Semin. Liver Dis.
2007;27;1
Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.
Am. J. Physiol. Gastrointest. Liver Physiol.
2007;292;2
Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.
Hepatology
2007;45;1

Reefer madness? Assessing the effects of cannabinoids with a less jaundiced eye.
J. Hepatol.
2007;46;1

KLF6 degradation after apoptotic DNA damage.
FEBS Lett.
2006;580;30

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Gastroenterology
2006;131;6


Diagnosis of hepatic fibrosis in patients with chronic hepatitis C.
Clin Liver Dis
2006;10;4


Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.
Semin. Liver Dis.
2006;26;4

Transcriptional regulation of stellate cell activation.
J. Gastroenterol. Hepatol.
2006;21 Suppl 3
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
Oncogene
2006;25;44

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.
J. Hepatol.
2006;45;1
Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
Clin. Cancer Res.
2006;12;12

Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo.
Hepatology
2006;43;3

Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6.
Blood
2006;107;4

Reversal of hepatic fibrosis -- fact or fantasy?
Hepatology
2006;43;2 Suppl 1
Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones.
Carcinogenesis
2006;27;2

Antifibrotic agents for liver disease.
Am. J. Transplant.
2006;6;1


Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation.
Cancer Res.
2005;65;20


Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10.
J. Immunol.
2005;175;6


Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Cancer Res.
2005;65;13



Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu.
Toxicol. Sci.
2005;85;1


Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.
J. Hepatol.
2005;42;4

A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Cancer Res.
2005;65;4

Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.
J. Clin. Invest.
2005;115;1

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.
Gut
2005;54;1



Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
Nature clinical practice. Gastroenterology & hepatology
2004;1;2

Lhx2-/- mice develop liver fibrosis.
Proc. Natl. Acad. Sci. U.S.A.
2004;101;47

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Hepatology
2004;40;5


Stellate cells: a moving target in hepatic fibrogenesis.
Hepatology
2004;40;5

Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2.
Gastroenterology
2004;127;4

Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells.
Oncogene
2004;23;41

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.
Gastroenterology
2004;127;3

Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
J. Hepatol.
2004;41;2

Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
Endocrinology
2004;145;8


Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.
Oncogene
2004;23;29

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.
Cancer Res.
2004;64;11
The answer: angiotensin II. The question: what do inflammation, oxidant stress and fibrogenesis have in common?
J. Hepatol.
2004;40;6

Retinoids in cancer chemoprevention.
Curr Cancer Drug Targets
2004;4;3

Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.
Gastroenterology
2004;126;4


Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
Int. J. Oncol.
2004;24;4

Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Carcinogenesis
2003;24;8


Krüppel cripples prostate cancer: KLF6 progress and prospects.
Am. J. Pathol.
2003;162;4

Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
Hepatology
2003;37;3


Treatment of hepatic fibrosis: almost there.
Curr Gastroenterol Rep
2003;5;1


Liver fibrosis -- from bench to bedside.
J. Hepatol.
2003;38 Suppl 1

Elevated expression of tyrosine kinase DDR2 in primary biliary cirrhosis.
Autoimmunity
2002;35;8

Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
Hepatology
2002;36;5

Hepatic fibrosis--role of hepatic stellate cell activation.
MedGenMed
2002;4;3

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.
Hepatology
2002;35;4

Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma.
Hepatology
2002;35;2

Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species.
Hepatology
2002;35;1

KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
Science
2001;294;5551

DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.
J. Clin. Invest.
2001;108;9

Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma.
Cancer Res.
2001;61;20

Transcriptional regulation in hepatic stellate cells.
Semin. Liver Dis.
2001;21;3
Expression and role of Bcl-xL in human hepatocellular carcinomas.
Hepatology
2001;34;1

Hepatic fibrosis. Pathogenesis and principles of therapy.
Clin Liver Dis
2001;5;2
Validation of a polymerase chain reaction method for the detection of rendered bovine-derived materials in feedstuffs.
J. Food Prot.
2001;64;4

Hepatology at Mount Sinai: the present and the future.
Mt. Sinai J. Med.
2001;68;2
Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
Hepatology
2001;33;3

Is liver fibrosis reversible?
N. Engl. J. Med.
2001;344;6
Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference.
Hepatology
2000;32;6

The effect of storage at 4 degrees C on the stability of ampicillin residues in raw milk.
Food Addit Contam
2000;17;8

Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex.
Am. J. Physiol. Gastrointest. Liver Physiol.
2000;279;1

An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro.
J. Lipid Res.
2000;41;6

The Krüppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact.
FEBS Lett.
2000;473;1

Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells.
Blood
2000;95;4
Evaluation of fibrosis and hepatitis C.
Am. J. Med.
1999;107;6B


The virtuosity of hepatic stellate cells.
Gastroenterology
1999;117;5

CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells.
Hepatology
1999;30;4

Activation of rat hepatic stellate cells leads to loss of glutathione S-transferases and their enzymatic activity against products of oxidative stress.
Hepatology
1999;30;4

Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
J. Gastroenterol. Hepatol.
1999;14;7

Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo.
J. Hepatol.
1999;30;6


Stellate cell activation in alcoholic fibrosis--an overview.
Alcohol. Clin. Exp. Res.
1999;23;5


Cytokines and fibrogenesis.
Semin. Liver Dis.
1999;19;2
Long-term functional results after manipulation of the frozen shoulder.
Md Med J
1999;48;1

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
J. Exp. Med.
1998;188;11


Molecular regulation of hepatic fibrogenesis.
J. Hepatol.
1998;29;5

Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis.
Proc. Natl. Acad. Sci. U.S.A.
1998;95;16

Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing.
Oncogene
1998;17;1

Cellular networks in hepatic fibrosis.
Digestion
1998;59;4

p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.
Cancer Res.
1997;57;20

Early genes induced in hepatic stellate cells during wound healing.
Gene
1997;195;2

Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells.
Oncogene
1997;15;1


Molecular mechanisms of hepatic fibrosis and principles of therapy.
J. Gastroenterol.
1997;32;3


Closing in on the signals of hepatic fibrosis.
Gastroenterology
1997;112;4

Scarring in alcoholic liver disease: new insights and emerging therapies.
Alcohol Health Res World
1997;21;4


Hepatic stellate cells.
Prog Liver Dis
1996;14
Parenchymal Fe and collagen gene expression: an iron-clad association?
Hepatology
1995;21;4

Hepatic lipocytes: a major target for endothelin-1.
J. Hepatol.
1995;22;2 Suppl

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture.
J. Clin. Invest.
1994;94;4

Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.
J. Clin. Invest.
1993;92;4


Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.
N. Engl. J. Med.
1993;328;25

Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF.
Am. J. Physiol.
1993;264;5 Pt 1

Parenchymal and nonparenchymal cell interactions in the liver.
Semin. Liver Dis.
1993;13;1

Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma.
Hepatology
1992;16;3

Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.
J. Clin. Invest.
1992;90;1

Neoplasms of the gastrointestinal tract and hepatobiliary system in acquired immunodeficiency syndrome.
Semin. Liver Dis.
1992;12;2
"Cuts both ways": collagenases, lipocyte activation and polyunsaturated lecithin.
Hepatology
1992;15;3

Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture.
Hepatology
1992;15;2

Apolipoprotein E is secreted by cultured lipocytes of the rat liver.
J. Lipid Res.
1991;32;1

Acetaldehyde and alcoholic fibrogenesis: fuel to the fire, but not the spark.
Hepatology
1990;12;3 Pt 1

Kaposi's sarcoma and lymphoma of the gut in AIDS.
Baillieres Clin. Gastroenterol.
1990;4;2

Hepatic fibrosis: new insights into pathogenesis.
Hosp. Pract. (Off. Ed.)
1990;25;5

Connective tissue biology and hepatic fibrosis: report of a conference.
Hepatology
1990;11;3

Cellular sources of collagen and regulation of collagen production in liver.
Semin. Liver Dis.
1990;10;1

Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.
J. Clin. Invest.
1989;84;6

Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.
J. Clin. Invest.
1989;84;4

Gastrointestinal and hepatobiliary neoplasms in AIDS.
Gastroenterol. Clin. North Am.
1988;17;3

Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan.
Gastroenterology
1988;95;2


Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer.
J. Clin. Invest.
1988;82;2

Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture.
Gastroenterology
1988;94;4
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.